Are you looking for some big dividend yields for a passive income boost?
If you are, it could pay to check out the two ASX dividend shares in this article.
They have been named as buys and tipped to provide income investors with generous dividend yields in the near term. Here's what you need to know about these shares:
Clearview Wealth Ltd (ASX: CVW)
Clearview Wealth could be an ASX dividend share to buy for passive income. That's the view of analysts at Morgans, which have an add rating and 81 cents price target on its shares.
Clearview is a life insurance business that partners with financial advisers to help Australians protect their wealth. At the end of FY 2024, it was managing over $370 million of in-force premiums and had relationships with over 1,000 Australian Financial Services Licensees.
Morgans is very positive on the company's outlook and is forecasting strong earnings growth in the coming years. It said:
CVW's significant multiyear Business Transformation Program has, in our view, shown clear signs of driving improved growth and profitability in recent years. We expect further benefits to flow from this program in the near term, and we see CVW's FY26 key business targets as achievable. With a robust balance sheet, and with our expectations for ~21% EPS CAGR over the next three years, we see CVW's current ~11x FY25F PE multiple as undemanding.
The broker expects this to support fully franked dividends of 3.6 cents per share in FY 2025 and 4.3 cents per share in FY 2026. Based on the current Clearview share price of 55 cents, this would mean dividend yields of 6.5% and 7.8%, respectively.
IPH Ltd (ASX: IPH)
Another ASX dividend share that could be a buy is IPH. It is an intellectual property (IP) services company with operations across the world.
Goldman Sachs is a big fan of the company. This morning, its analysts retained their buy rating on its shares with a trimmed price target of $7.50.
The broker believes that the recent underperformance of its shares has created a buying opportunity. It said:
IPH has continued to underperform the market, in our view based on concerns regarding the organic growth trajectory of the business (filings volumes and cost reinvestment) and potential for further M&A. In our view, IPH's valuation is compelling at ~11x P/E for a stable, cash-generative business with solid mid single organic EPS growth and a ~7% dividend yield.
We await IPH's AGM (Nov 14) for an update on IPH's organic growth performance and synergies from Canadian acquisitions. We incorporate the B&P acquisition post completion, driving +4%/+4%/+4% FY25/26/27E EBITDA increases and -4%/-3%/-3% EPS changes after accounting for the equity raising, with our 12m TP -9% to A$7.50/share. Buy.
As for income, Goldman is forecasting fully franked dividends of 35.8 cents per share in FY 2025 and then 38.9 cents per share in FY 2026. Based on the current IPH share price of $5.66 this represents yields of 6.3% and 6.9%, respectively.
